TrialCardiovascular diabetology2016

Effects of the glucagon-like peptide-1 receptor agonist liraglutide on systolic function in patients with coronary artery disease and type 2 diabetes: a randomized double-blind placebo-controlled crossover study.

Preman Kumarathurai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.